Publications
Print PDF
ANDA Litigation: Patents are Being Challenged Sooner, OxyContin Draws Most Fire
November 6, 2014
The Pink Sheet

Axinn Partner Chad Landmon was quoted in The Pink Sheet’s article, “ANDA Litigation: Patents are Being Challenged Sooner, OxyContin Draws Most Fire.” The Pink Sheet is produced by Pharma & Med Tech Business Intelligence.  

Click here to access the article.

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.